IR
IRadimed Corporation
IRMD · NASDAQ
$81.87 -1.40% (-$1.16)
1M -4.39%
Market Cap $1.05B
P/E Ratio 45.39x
Div. Yield 1.55%
ROE 23.45%
Bulios Fair Price
$48.43
40.8% downside
Current Price
$81.87
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IRMD is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
9 /100
Expensive P/FCF 41.98x
P/E 45.39x
P/B 10.29x
Growth
93 /100
Growing FCF growth 28.13%
EPS growth 19.71%
Book val. growth 8.70%
Profitability
100 /100
Strong Op. margin 31.92%
Gross margin 75.86%
FCF margin 28.88%
Quality
94 /100
Excellent ROA 20.05%
ROIC 20.18%
Asset turnover 0.75x
Debt
100 /100
Low Net debt/EBITDA -1.90x
Debt/Equity 0.00x
Current ratio 9.46x
Stability
100 /100
Stable EPS volatility 11.02%
Beta 0.90x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IRMD
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Roger E. Susi
Employees
166
Headquarters
Orlando
Upcoming events
02 NOV
Earnings
Upcoming earnings report